Results 81 to 90 of about 12,794 (204)

H1N1‐Related Hemophagocytic Lymphohistiocytosis Complicated by Severe Rhabdomyolysis in a Pediatric Patient: A First Case Report

open access: yesCase Reports in Pediatrics, Volume 2026, Issue 1, 2026.
Background Hemophagocytic lymphohistiocytosis (HLH) is a rare and often life‐threatening hyperinflammatory disorder, mainly caused by infections, malignancies, or autoimmune diseases. Influenza A (H1N1) has occasionally been linked to pediatric HLH cases.
Lucia Marseglia   +8 more
wiley   +1 more source

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilatorassociated pneumonia [PDF]

open access: yes, 2012
INTRODUCTION: The aim of this study was to compare a 7-day course of doripenem to a 10-day course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram-negative bacteria.
Chastre, Jean   +8 more
core   +2 more sources

Descending necrotizing mediastinitis: minimally invasive thoracic surgical treatment [PDF]

open access: yes, 2010
OBJECTIVE: To report a case series of patients with descending necrotizing mediastinitis (DNM) who were treated with minimally invasive thoracic surgery.
Daud, Danilo Félix   +5 more
core   +2 more sources

3542 Torsade de pointes/QT prolongation risks with antibiotics: A contemporary analysis of the FDA Adverse Event Reporting System

open access: yesJournal of Clinical and Translational Science, 2019
OBJECTIVES/SPECIFIC AIMS: Macrolides, linezolid, imipenem-cilastatin, fluoroquinolones, penicillin combinations, and ceftriaxone are known to be associated with Torsade de pointes/QT prolongation (TdP/QTP). Other antibiotics may also lead to TdP/QTP, but
Chengwen Teng   +2 more
doaj   +1 more source

A Randomized Prospective Study of Cefepime Plus Metronidazole with Imipenem-Cilastatin in the Treatment of Intra-abdominal Infections [PDF]

open access: yes, 2018
: Background: : Presumptive antimicrobial therapy is an important aspect of the management of intra-abdominal infections. Together with surgery, antimicrobial combinations are still widely used to achieve the required spectrum of activity.
Caviezel, A.   +6 more
core  

Ertapenem Resistance of Escherichia coli

open access: yesEmerging Infectious Diseases, 2007
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days.
Marie-Frédérique Lartigue   +4 more
doaj   +1 more source

NECROTIZING FASCIITIS OF THE POSTERIOR CERVICAL COMPARTMENT: AN ATYPICAL CASE DUE TO STREPTOCOCCUS AGALACTIAE [PDF]

open access: yes, 2012
Necrotizing fasciitis is a fulminant infection that affects the deep and superficial fascia while initially sparing the overlying skin and underlying muscle.
Abramo, Alessandro   +3 more
core   +1 more source

Radical cystectomy: Analysis of postoperative course [PDF]

open access: yes, 2010
Background/Aim. Radical cystectomy is a method of choice in the therapy of infiltrative bladder cancer. The aim of this research was to analyze postoperative course after radical cystectomy (length of hospitalization, most frequent complications and ...
Jeremić Dimitrije   +4 more
core   +1 more source

Ultrasound-guided thoracentesis for diagnosing Nocardia beijingensis-related empyema in a patient with systemic lupus erythematosus: A rare case report

open access: yesRadiology Case Reports
Infections caused by Nocardia species are relatively rare and primarily affect immunocompromised patients. There are few reported cases of Nocardia beijingensis causing empyema in patients with systemic lupus erythematosus (SLE).
Ngoc Duong-Minh, MD   +3 more
doaj   +1 more source

First case of Nocardia amamiensis pulmonary infection in Mexico

open access: yesNew Microbes and New Infections, 2017
We report a case of Nocardia amamiensis pulmonary infection in a 43-year-old immunocompromised woman. The patient was treated with imipenem/cilastatin and trimethoprim/sulfamethoxazole and had a favourable outcome.
A. Martinez-Gamboa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy